FDA Finds Impurity In Suspect Heparin Batches

Law360, New York (March 19, 2008, 12:00 AM EDT) -- Federal regulators have identified a contaminant in batches of heparin linked to 19 deaths and hundreds of allergic reactions in the U.S. and are working to figure out how the blood thinner got contaminated.

In a press conference Wednesday, the U.S. Food and Drug Administration identified the contaminant as oversulfated chondroitin sulfate, a chemically altered form of chondroitin sulfate.

Tests on heparin batches originating from China have shown that the contaminant accounts for as much as 50% of the active ingredient.

While chondroitin sulfate is naturally...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.